{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:31:45Z","timestamp":1777498305526,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/014199-9"],"award-info":[{"award-number":["2015\/014199-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24993-0"],"award-info":[{"award-number":["2017\/24993-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/12381-7"],"award-info":[{"award-number":["2016\/12381-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/17285-6"],"award-info":[{"award-number":["2016\/17285-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10637-019-00846-9","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:03:12Z","timestamp":1566475392000},"page":"899-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours"],"prefix":"10.1007","volume":"38","author":[{"given":"B\u00e1rbara","family":"dos Santos Passaia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Lucas","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Brito","family":"da Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Marinho","family":"de Paula Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Carlos Lipreri","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Claudia Nogueira","family":"Zerbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Candida Barisson Villares","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-7099","authenticated-orcid":false,"given":"Claudimara Ferini Pacicco","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014) Adrenocortical carcinoma. Endocr Rev 35:282\u2013326","journal-title":"Endocr Rev"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","volume":"30","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, Hammer GD, Giordano TJ, Verhaak RGW, Zheng S, Verhaak RGW, Giordano TJ, Hammer GD, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assi\u00e9 G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida M, Barisson Fragoso MC, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA, Benz C, Ally A, Balasundaram M, Bowlby R, Brooks D, Butterfield YSN, Carlsen R, Dhalla N, Guin R, Holt RA, Jones SJM, Kasaian K, Lee D, Li HI, Lim L, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Mungall K, Sadeghi S, Schein JE, Sipahimalani P, Tam A, Thiessen N, Park PJ, Kroiss M, Gao J, Sander C, Schultz N, Jones CD, Kucherlapati R, Mieczkowski PA, Parker JS, Perou CM, Tan D, Veluvolu U, Wilkerson MD, Hayes DN, Ladanyi M, Quinkler M, Auman JT, Latronico AC, Mendonca BB, Sibony M, Sanborn Z, Bellair M, Buhay C, Covington K, Dahdouli M, Dinh H, Doddapaneni H, Downs B, Drummond J, Gibbs R, Hale W, Han Y, Hawes A, Hu J, Kakkar N, Kalra D, Khan Z, Kovar C, Lee S, Lewis L, Morgan M, Morton D, Muzny D, Santibanez J, Xi L, Dousset B, Groussin L, Lib\u00e9 R, Chin L, Reynolds S, Shmulevich I, Chudamani S, Liu J, Lolla L, Wu Y, Yeh JJ, Balu S, Bodenheimer T, Hoyle AP, Jefferys SR, Meng S, Mose LE, Shi Y, Simons JV, Soloway MG, Wu J, Zhang W, Mills Shaw KR, Demchok JA, Felau I, Sheth M, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J(J), Davidsen T, Crawford C, Hutter CM, Sofia HJ, Roach J, Bshara W, Gaudioso C, Morrison C, Soon P, Alonso S, Baboud J, Pihl T, Raman R, Sun Q, Wan Y, Naresh R, Arachchi H, Beroukhim R, Carter SL, Cho J, Frazer S, Gabriel SB, Getz G, Heiman DI, Kim J, Lawrence MS, Lin P, Noble MS, Saksena G, Schumacher SE, Sougnez C, Voet D, Zhang H, Bowen J, Coppens S, Gastier-Foster JM, Gerken M, Helsel C, Leraas KM, Lichtenberg TM, Ramirez NC, Wise L, Zmuda E, Baylin S, Herman JG, LoBello J, Watanabe A, Haussler D, Radenbaugh A, Rao A, Zhu J, Bartsch DK, Sbiera S, Allolio B, Deutschbein T, Ronchi C, Raymond VM, Vinco M, Shao L, Amble L, Bootwalla MS, Lai PH, van den Berg DJ, Weisenberger DJ, Robinson B, Ju Z, Kim H, Ling S, Liu W, Lu Y, Mills GB, Sircar K, Wang Q, Yoshihara K, Laird PW, Fan Y, Wang W, Shinbrot E, Reincke M, Weinstein JN, Meier S, Defreitas T (2016) Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 30:363","journal-title":"Cancer Cell"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assie","year":"2014","unstructured":"Assie G, Letouze E, Fassnacht M, Jouinot A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K, Rene-Corail F et al (2014) Integrated genomic characterization of adrenocortical carcinoma. Nat Genet 46:607\u2013612","journal-title":"Nat Genet"},{"key":"846_CR4","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0114","volume-title":"Apoptosis regulation in adrenocortical carcinoma","author":"SS Pereira","year":"2019","unstructured":"Pereira SS, Monteiro MP, Antonini SRR, Pignatelli D (2019) Apoptosis regulation in adrenocortical carcinoma. In: Apoptosis regulation in adrenocortical carcinoma. Endocr Connect"},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-17-0976","volume":"179","author":"SS Pereira","year":"2018","unstructured":"Pereira SS, Monteiro MP, Bourdeau I, Lacroix A, Pignatelli D (2018) Mechanisms of endocrinology: Cell cycle regulation in adrenocortical carcinoma. Eur J Endocrinol 179:R95\u2013R110","journal-title":"Eur J Endocrinol"},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12020-012-9719-7","volume":"42","author":"M Terzolo","year":"2012","unstructured":"Terzolo M, Ardito A, Zaggia B, Laino F, Germano A, De Francia S, Daffara F, Berruti A (2012) Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine 42:521\u2013525","journal-title":"Endocrine"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/0008-5472.CAN-06-3767","volume":"67","author":"AN West","year":"2007","unstructured":"West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R et al (2007) Gene expression profiling of childhood adrenocortical tumors. Cancer Res 67:600\u2013608","journal-title":"Cancer Res"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","volume":"27","author":"JA Wieneke","year":"2003","unstructured":"Wieneke JA, Thompson LD, Heffess CS (2003) Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 27:867\u2013881","journal-title":"Am J Surg Pathol"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1517\/14728222.2011.620951","volume":"15","author":"B Belletti","year":"2011","unstructured":"Belletti B, Baldassarre G (2011) Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 15:1249\u20131266","journal-title":"Expert Opin Ther Targets"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5483\/BMBRep.2014.47.12.020","volume":"47","author":"JA Machado-Neto","year":"2014","unstructured":"Machado-Neto JA, Saad ST, Traina F (2014) Stathmin 1 in normal and malignant hematopoiesis. BMB Rep 47:660\u2013665","journal-title":"BMB Rep"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12967-016-1000-z","volume":"14","author":"R Biaoxue","year":"2016","unstructured":"Biaoxue R, Xiguang C, Hua L, Shuanying Y (2016) Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments. J Transl Med 14:279","journal-title":"J Transl Med"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1586\/14737140.8.9.1461","volume":"8","author":"S Rana","year":"2008","unstructured":"Rana S, Maples PB, Senzer N, Nemunaitis J (2008) Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8:1461\u20131470","journal-title":"Expert Rev Anticancer Ther"},{"key":"846_CR13","doi-asserted-by":"crossref","first-page":"78994","DOI":"10.18632\/oncotarget.12982","volume":"7","author":"R Biaoxue","year":"2016","unstructured":"Biaoxue R, Hua L, Wenlong G, Shuanying Y (2016) Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis. Oncotarget 7:78994\u201379007","journal-title":"Oncotarget"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1245\/s10434-017-6296-2","volume":"25","author":"A Aronova","year":"2018","unstructured":"Aronova A, Min IM, Crowley MJP, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey III TJ (2018) STMN1 is overexpressed in adrenocortical carcinoma and promotes a more aggressive phenotype in vitro. Ann Surg Oncol 25:792\u2013800","journal-title":"Ann Surg Oncol"},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","volume":"40","author":"SK Lau","year":"2009","unstructured":"Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757\u2013768","journal-title":"Hum Pathol"},{"key":"846_CR16","first-page":"5488","volume":"50","author":"AF Gazdar","year":"1990","unstructured":"Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, La Rocca RV (1990) Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 50:5488\u20135496","journal-title":"Cancer Res"},{"key":"846_CR17","first-page":"691","volume":"51","author":"A Leibovitz","year":"1973","unstructured":"Leibovitz A, McCombs WM 3rd, Johnston D, McCoy CE, Stinson JC (1973) New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex. J Natl Cancer Inst 51:691\u2013697","journal-title":"J Natl Cancer Inst"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","volume":"19","author":"K Yamamoto","year":"1999","unstructured":"Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M. Mol Cell Biol 19:8469\u20138478","journal-title":"Mol Cell Biol"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1210\/jc.2008-0065","volume":"93","author":"MQ Almeida","year":"2008","unstructured":"Almeida MQ, Fragoso MC, Lotfi CF, Santos MG, Nishi MY, Costa MH, Lerario AM, Maciel CC, Mattos GE, Jorge AA et al (2008) Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J Clin Endocrinol Metab 93:3524\u20133531","journal-title":"J Clin Endocrinol Metab"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mce.2012.12.029","volume":"371","author":"MM Franca","year":"2013","unstructured":"Franca MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Kuick RD, Hammer GD, Lotfi CF (2013) POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells. Mol Cell Endocrinol 371:140\u2013147","journal-title":"Mol Cell Endocrinol"},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","volume":"27","author":"A de Reynies","year":"2009","unstructured":"de Reynies A, Assie G, Rickman DS, Tissier F, Groussin L, Rene-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27:1108\u20131115","journal-title":"J Clin Oncol"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/EJE-11-0806","volume":"166","author":"MC Fragoso","year":"2012","unstructured":"Fragoso MC, Almeida MQ, Mazzuco TL, Mariani BM, Brito LP, Goncalves TC, Alencar GA, Lima Lde O, Faria AM, Bourdeau I et al (2012) Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. Eur J Endocrinol 166:61\u201367","journal-title":"Eur J Endocrinol"},{"key":"846_CR24","first-page":"100","volume":"72","author":"DC Rowlands","year":"1995","unstructured":"Rowlands DC, Williams A, Jones NA, Guest SS, Reynolds GM, Barber PC, Brown G (1995) Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages. Lab Investig 72:100\u2013113","journal-title":"Lab Investig"},{"key":"846_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13046-017-0575-4","volume":"36","author":"HL Ma","year":"2017","unstructured":"Ma HL, Jin SF, Ju WT, Fu Y, Tu YY, Wang LZ, Jiang L, Zhang ZY, Zhong LP (2017) Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma. J Exp Clin Cancer Res 36:109","journal-title":"J Exp Clin Cancer Res"},{"key":"846_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.21736","volume":"46","author":"S Singer","year":"2007","unstructured":"Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, Breuhahn K (2007) Protumorigenic overexpression of stathmin\/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 46:759\u2013768","journal-title":"Hepatology"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1210\/jc.2004-0963","volume":"90","author":"EM Pinto","year":"2005","unstructured":"Pinto EM, Billerbeck AE, Fragoso MC, Mendonca BB, Latronico AC (2005) Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein. J Clin Endocrinol Metab 90:2976\u20132981","journal-title":"J Clin Endocrinol Metab"},{"key":"846_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fendo.2018.00038","volume":"9","author":"BDS Passaia","year":"2018","unstructured":"Passaia BDS, Dias MH, Kremer JL, Antonini SRR, de Almeida MQ, Fragoso M, Lotfi CFP (2018) TCF21\/POD-1, a Transcritional regulator of SF-1\/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors. Front Endocrinol (Lausanne) 9:38","journal-title":"Front Endocrinol (Lausanne)"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3892\/or.2012.2157","volume":"29","author":"F Liu","year":"2013","unstructured":"Liu F, Sun YL, Xu Y, Wang LS, Zhao XH (2013) Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma. Oncol Rep 29:419\u2013424","journal-title":"Oncol Rep"},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"29573","DOI":"10.18632\/oncotarget.4998","volume":"6","author":"JA Machado-Neto","year":"2015","unstructured":"Machado-Neto JA, de Melo CP, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand-Metze I, Costa FF, Saad ST, Traina F (2015) Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget 6:29573\u201329584","journal-title":"Oncotarget"},{"key":"846_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00405","volume":"3","author":"JA Machado-Neto","year":"2017","unstructured":"Machado-Neto JA, Rodrigues Alves APN, Fernandes JC, Coelho-Silva JL, Scopim-Ribeiro R, Fenerich BA, da Silva FB, Scheucher PS, Simoes BP, Rego EM et al (2017) Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells. Heliyon 3:e00405","journal-title":"Heliyon"},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/SLA.0b013e3182402d21","volume":"255","author":"MJ Demeure","year":"2012","unstructured":"Demeure MJ, Stephan E, Sinari S, Mount D, Gately S, Gonzales P, Hostetter G, Komorowski R, Kiefer J, Grant CS, Han H, von Hoff DD, Bussey KJ (2012) Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer. Ann Surg 255:140\u2013146","journal-title":"Ann Surg"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3892\/ijo.2015.2902","volume":"46","author":"L Cerquetti","year":"2015","unstructured":"Cerquetti L, Sampaoli C, De Salvo M, Bucci B, Argese N, Chimento A, Vottari S, Marchese R, Pezzi V, Toscano V et al (2015) C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines. Int J Oncol 46:2231\u20132240","journal-title":"Int J Oncol"},{"key":"846_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/EJE-11-0918","volume":"166","author":"A Berruti","year":"2012","unstructured":"Berruti A, Sperone P, Ferrero A, Germano A, Ardito A, Priola AM, De Francia S, Volante M, Daffara F, Generali D et al (2012) Phase II study of weekly paclitaxel and sorafenib as second\/third-line therapy in patients with adrenocortical carcinoma. Eur J Endocrinol 166:451\u2013458","journal-title":"Eur J Endocrinol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00846-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-019-00846-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00846-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:38:18Z","timestamp":1678509498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-019-00846-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s10637-019-00846-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent was obtained from all individual participants included in the study prior to sample collection, and the study was approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}